The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study-Reference-Cited by-同舟云学术

The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study

Published:2020-07 Issue:4 Volume:29 Page:350-356
ISSN:0959-8278
Container-title:European Journal of Cancer Prevention
language:en
Short-container-title:

Author:

Grandi Giovanni,Del Savio Maria Chiara,Sammarini Margaret,Cortesi Laura,Toss Angela,Piombino Claudia,Facchinetti Fabio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Reference22 articles.

1. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.;Antoniou;Am J Hum Genet,2003

2. Reactivity of a monoclonal antibody with human ovarian carcinoma.;Bast;J Clin Invest,1981

3. Dynamic prediction of outcome for patients with ovarian cancer: application of a joint model for longitudinal cancer antigen 125 values.;Cao;Int J Gynecol Cancer,2018

4. Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.;Chen;Fam Cancer,2014

5. A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer.;Chiang;J Gynecol Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal study;2024-05-31

2. Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study;Archives of Gynecology and Obstetrics;2022-04-24

3. The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance;Menopause;2021-11-01

4. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants’ characteristics at surgery: a prospective study;Menopause;2021-02-01